.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Effective diabetic wound treatment remains a critical challenge for clinicians due to persistent oxidative stress and cellular dysfunction. In a groundbreaking study, researchers developed artificial nanovesicles enriched with mitochondrial proteins to address these barriers. These cell-derived nanovesicles (CNVs) provide a novel way to restore organelle function in damaged tissues.
The research team utilized a top-down approach to create CNVs from human umbilical cord mesenchymal stem cells (hUC-MSCs). Unlike naturally secreted extracellular vesicles, these artificial nanovesicles selectively encapsulate high concentrations of mitochondria-associated proteins. Consequently, they effectively reduce reactive oxygen species (ROS) levels and specifically restore mitochondrial membrane potential and morphology. This restoration involves several key metabolic pathways, including the ALDH2/HADHA/HADHB and IDH2/GSR/GSH axes. Therefore, this technology offers a more targeted strategy than conventional cell-based therapies.
During in vivo experiments, the CNVs significantly accelerated the healing of wounds in diabetic mouse models. By restoring mitochondrial complexes I, III, and V, the nanovesicles improved cellular energy production and survival. This study highlights the therapeutic potential of using organelle-associated proteins for complex disease management. As a result, this organelle-based strategy may soon offer a promising alternative for patients suffering from non-healing ulcers.
These nanovesicles deliver essential mitochondrial proteins to damaged cells. This process helps neutralize harmful oxidative stress and restores the energy-producing capacity of the mitochondria, which is often impaired in diabetic conditions.
Natural vesicles often have limited yields of specific mitochondrial components. The artificial top-down approach allows for the selective enrichment of therapeutic proteins, making the treatment more potent and efficient for healing chronic wounds.
References
Xia J et al. Mitochondrial protein-enriched artificial nanovesicles: mitochondrial recovery and antioxidation for diabetic wound treatment. J Nanobiotechnology. 2026 Feb 05. doi: 10.1186/s12951-026-04100-2. PMID: 41645206.
Huang J et al. Stem Cell-Derived Extracellular Vesicles: Promising Therapeutic Opportunities for Diabetic Wound Healing. Front Endocrinol. 2024. doi: 10.3389/fendo.2024.1350000.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Effective diabetic wound treatment remains a critical challenge for clinicians due to persistent oxidative stress and cellular dysfunction. In a groundbreak...
8 months ago
A comprehensive meta-analysis updates clinical guidelines on nonopioid analgesics for cancer pain. While NSAIDs offer measurable pain relief alone or with opioids, acetaminophen shows limited additive benefit, guiding refined palliative analgesic strategies.
Today
A large UK cohort study of 1.4 million women shows that pregnancy complications, including gestational diabetes, hypertension, and preterm birth, substantially raise long-term risks for hypertension, chronic kidney disease, type 2 diabetes, and cardiovascular events, highlighting early postpartum intervention needs.
Yesterday
A cross-sectional study reveals that hypertension knowledge, illness perceptions, depression, and substance use significantly predict self-care behaviors. Addressing mental health and cognitive beliefs in primary care is crucial for optimal blood pressure control and cardiovascular disease prevention.
Today
This clinical overview examines recent advancements in lumbar disc herniation surgery, comparing microscopic and full-endoscopic discectomy while highlighting biportal techniques and emerging motion-preserving innovations for spine specialists.
Today
A breakthrough study reveals that loss of SELENOT in hypothalamic POMC neurons triggers premature cellular senescence, ATF6α stress activation, and ER calcium depletion, linking neuroendocrine decay to metabolic disease.
Today
